Clincosm LogoSign in Get a demo

myelodysplastic syndrome

Showing NaN - NaN of 117
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Tetanus)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Tetanus
  • Houston, Texas
  • +1 more
Apr 20, 2020

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Trial in Houston (Azacitidine, BRD4

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 19, 2020

Myelodysplastic Syndrome, Leukemia Trial in Houston (procedure, drug, other, radiation)

Completed
  • Myelodysplastic Syndrome
  • Leukemia
  • Cord Blood Infusion
  • +11 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 27, 2020

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (INCB018424)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 5, 2020

Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +8 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

related Acute Myeloid Leukemia/Myelodysplastic Syndrome

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndrome
  • Interview
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 10, 2020

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);

Completed
Has Results
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Erlotinib Hydrochloride
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Dec 18, 2019

Myelodysplastic Syndrome Trial in United States (CC-11006)

Terminated
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +6 more
Dec 11, 2019

Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (FT-1101, Azacitidine)

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • Los Angeles, California
  • +7 more
Jun 25, 2019

Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in Houston (Decitabine, Valproic Acid)

Completed
Has Results
  • Myelodysplastic Syndrome
  • Acute Myelogenous Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 2, 2019

Myelodysplastic Syndrome, MDS Trial in Spain, United States (GSK2879552, Azacitidine)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • Myelodysplastic Syndromes
  • Augusta, Georgia
  • +5 more
Apr 23, 2019

Myelodysplastic Syndrome Trial in Worldwide (MEDI4736 Evaluate MEDI4736 in MDS, VIDAZA, tremelimumab)

Completed
  • Myelodysplastic Syndrome
  • MEDI4736 Evaluate MEDI4736 in MDS
  • +2 more
  • Scottsdale, Arizona
  • +20 more
May 9, 2019

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome, Hematologic Malignancies Trial in France, United States (AG881)

Completed
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Aurora, Colorado
  • +5 more
Mar 6, 2019

Myelodysplastic Syndrome Trial in United States (vadastuximab talirine, Azacitidine, Placebo (for 33A))

Terminated
Has Results
  • Myelodysplastic Syndrome
  • vadastuximab talirine
  • +2 more
  • Gilbert, Arizona
  • +33 more
Jan 23, 2019

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (BVD-523)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Los Angeles, California
  • +4 more
Jan 9, 2019

Myelodysplastic Syndrome Trial in Houston (OPN-305)

Completed
  • Myelodysplastic Syndrome
  • Houston, Texas
    Research Site
Jan 24, 2019

Myelodysplastic Syndrome Trial in United States (OPN-305)

Completed
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +3 more
Jan 24, 2019

Myelodysplastic Syndrome Trial in Houston (Decitabine, Clofarabine)

Completed
Has Results
  • Myelodysplastic Syndrome
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 17, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Gelonin, Busulfan, Fludarabine)

Terminated
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gelonin
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 30, 2018

Myelodysplastic Syndrome Trial in United States (pracinostat, Placebo, Azacitidine)

Completed
  • Myelodysplastic Syndrome
  • Mobile, Alabama
  • +23 more
Sep 11, 2018

Myelodysplastic Syndrome Trial in Houston (LBH589)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • Houston, Texas
    UT MD Anderson Cancer Center
Jul 23, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Leukemia Trial in Houston (Procrit)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
May 1, 2018

Acute Lymphoblastic Leukemia, ALL, Acute Myelogenous Leukemia Trial in Houston (IL-2)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +9 more
  • IL-2
  • Houston, Texas
  • +1 more
Apr 3, 2018

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders Trial in Canada, United States (Clofarabine,

Terminated
  • Myelodysplastic Syndrome
  • +9 more
  • Phoenix, Arizona
  • +6 more
Feb 13, 2018

Myelodysplastic Syndrome Trial in Worldwide (eltrombopag olamine, Placebo)

Completed
  • Myelodysplastic Syndrome
  • eltrombopag olamine
  • Placebo
  • Birmingham, Alabama
  • +64 more
Nov 8, 2017